2. Program Goals

4. What is Atopic Dermatitis?

5. Recognizing Atopic Dermatitis

6. Recognizing Atopic Dermatitis

7. Prevalence of Atopic Dermatitis

8. AD and Allergic Disease

9. Pathologic and Mechanistic Suppositions in AD

10. Pathologic and Mechanistic Suppositions in AD

12. Role of PDE and Inflammatory Cell Dysfunction in AD

13. Role of PDE and Inflammatory Cell Dysfunction in AD (cont)

15. cAMP-PDE Activity in AD Patients Elevated

16. Introduction to Phosphodiesterase Enzymes

19. Translating Science Into Practice

20. Topical Corticosteroids: First-line AD Treatment Balance is Important

21. Topical Calcineurin Inhibitors

22. Need for New Topical Therapies for AD

23. Eczema (AD) Action Plans

24. OPA-15406: Phase 2

25. Crisaborole: Phase 3

26. E6005*: Phase 2

27. Emerging Therapies for AD Systemic Agents

28. Summary

29. Abbreviations